<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="/styles/rss-style.xsl"?>

<rss version="2.0"
 xmlns:blogChannel="http://backend.userland.com/blogChannelModule"
>

<channel>
<title>teodesian.net</title>
<link>http://teodesian.net//posts/3bfe462b-13f9-11ec-bdd7-b984f031cbb2?format=xml</link>
<description>teodesian.net : /posts/3bfe462b-13f9-11ec-bdd7-b984f031cbb2</description>
<language>en</language>
<pubDate>2026-04-25T10:34:34</pubDate>
<lastBuildDate>2026-04-25T10:34:34</lastBuildDate>

<image>
<title>teodesian.net</title>
<url>/favicon.ico</url>
<link>http://teodesian.net</link>
<width>32</width>
<height>32</height>
<description>teodesian.net favicon</description>
</image>
<item>
<title>CRISPR carcinogenisis</title>
<link>http://teodesian.net/posts/3bfe462b-13f9-11ec-bdd7-b984f031cbb2</link>
<description><![CDATA[<blockquote>
“We found that cutting the genome with CRISPR-Cas9 induced the activation of … p53,” said Emma Haapaniemi, the lead author of the Karolinska study. That “makes editing much more difficult.”
<br /><br />
The flip side of p53 repairing CRISPR edits, or killing cells that accept the edits, is that cells that survive with the edits do so precisely because they have a dysfunctional p53 and therefore lack this fix-it-or-kill-it mechanism.
<br /><br />
The reason why that could be a problem is that p53 dysfunction can cause cancer. And not just occasionally. P53 mutations are responsible for nearly half of ovarian cancers; 43 percent of colorectal cancers; 38 percent of lung cancers; nearly one-third of pancreatic, stomach, and liver cancers; and one-quarter of breast cancers, among others.
</blockquote>

Yet more trouble for the approach.  I think the knowledge about the new type of DNA needs to be expanded before we truly understand this.]]></description>
<author>doge</author>
<guid isPermaLink="true">http://teodesian.net/posts/3bfe462b-13f9-11ec-bdd7-b984f031cbb2</guid>
<pubDate>2018-06-13T19:42:08</pubDate>
<enclosure type="text/html" url="http://teodesian.net/posts/3bfe462b-13f9-11ec-bdd7-b984f031cbb2" />
</item>
<item>
<title>CRISPR carcinogenisis</title>
<link>http://teodesian.net/posts/1528918928</link>
<description><![CDATA[<blockquote>
“We found that cutting the genome with CRISPR-Cas9 induced the activation of … p53,” said Emma Haapaniemi, the lead author of the Karolinska study. That “makes editing much more difficult.”
<br /><br />
The flip side of p53 repairing CRISPR edits, or killing cells that accept the edits, is that cells that survive with the edits do so precisely because they have a dysfunctional p53 and therefore lack this fix-it-or-kill-it mechanism.
<br /><br />
The reason why that could be a problem is that p53 dysfunction can cause cancer. And not just occasionally. P53 mutations are responsible for nearly half of ovarian cancers; 43 percent of colorectal cancers; 38 percent of lung cancers; nearly one-third of pancreatic, stomach, and liver cancers; and one-quarter of breast cancers, among others.
</blockquote>

Yet more trouble for the approach.  I think the knowledge about the new type of DNA needs to be expanded before we truly understand this.]]></description>
<author>doge</author>
<guid isPermaLink="true">http://teodesian.net/posts/1528918928</guid>
<pubDate>2018-06-13T19:42:08</pubDate>
<enclosure url="http://teodesian.net/posts/1528918928" type="text/html" />
</item>
</channel>
</rss>
